Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | FBP1 | P09467 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3222257 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTP53TDP1NPC1 | |
| SCHEMBL10410990 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTP53TDP1NPC1 | |
| SCHEMBL31380623 | 0.84 | TP53 (0.44) | ALDH1A1TSHRTP53TDP1NPC1 | |
| SCHEMBL31380625 | 0.84 | TP53 (0.44) | ALDH1A1TSHRTP53TDP1NPC1 | |
| SCHEMBL31380608 | 0.84 | TP53 (0.44) | ALDH1A1TSHRTP53TDP1NPC1 | |
| SCHEMBL31380589 | 0.84 | TP53 (0.44) | ALDH1A1TSHRTP53TDP1NPC1 | |
| SCHEMBL20424935 | 0.81 | NPC1 (0.49) | ALDH1A1TSHRTP53TDP1NPC1 | |
| SCHEMBL29964263 | 0.81 | NPC1 (0.49) | ALDH1A1TSHRTP53TDP1NPC1 | |
| SCHEMBL30268861 | 0.79 | TP53 (0.56) | ALDH1A1TP53TDP1NPC1CASP3 | |
| SCHEMBL28235567 | 0.79 | ALDH1A1 (0.54) | ALDH1A1TSHRNPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140142343-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2014-05-22 | — | — | US | disclosed |
| US-20140142343-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2014-05-22 | — | — | US | disclosed |
| US-20140142343-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2014-05-22 | — | — | US | disclosed |
| US-8709994-B2 | Fragrance compounds | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2014-04-29 | — | — | US | disclosed |
| EP-2077986-B1 | NOVEL FRAGRANCE COMPOUNDS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2013-12-04 | — | — | EP | disclosed |
| EP-2657218-A1 | Novel Fragrance Compounds | Givaudan Nederland Services B.V. (NL) | 2013-10-30 | — | — | EP | disclosed |
| EP-2657218-A1 | Novel Fragrance Compounds | Givaudan Nederland Services B.V. (NL) | 2013-10-30 | — | — | EP | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| EP-2077986-A1 | NOVEL FRAGRANCE COMPOUNDS | Givaudan Nederland Services B.V. (NL) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008053148-A1 | NOVEL FRAGRANCE COMPOUNDS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008053148-A1 | NOVEL FRAGRANCE COMPOUNDS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069287-A1 | Novel Fragrance Compounds | C1S, C5, FADS1 | ALDH1A1 1089/4885TSHR 4380/4885TP53 1490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.